feed,title,long_url,short_url
BioRxiv,No SARS-CoV-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic,https://biorxiv.org/cgi/content/short/2020.07.30.228213v1?rss=1,https://j.mp/2P9J4XT
BioRxiv,"A Next Generation Bivalent Human Ad5 COVID-19 Vaccine Delivering Both Spike and Nucleocapsid Antigens Elicits Th1 Dominant CD4+, CD8+ T-cell and Neutralizing Antibody Responses",https://biorxiv.org/cgi/content/short/2020.07.29.227595v1?rss=1,https://j.mp/2DiDLmg
